Skip to content

Drug Wastage : Observational Study in Intensive Care Units in France

Drug Wastage : Observational Study in Intensive Care Units in France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05553054
Acronym
GAME-OVER
Enrollment
1066
Registered
2022-09-23
Start date
2022-11-08
Completion date
2023-03-15
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Use

Keywords

Intravenous (IV) drug, Waste, Intensive Care Unit (ICU), Environmental sustainability, Drug wastage, Care Eco-design

Brief summary

Environmental awareness leads medical field to question its responsibility and possibilities for action. Drug residues can have a major environmental impact as per their bioaccumulation, toxicity and persistence characteristics, depending on where they are discarded. In France, drug residues should be disposed of by incineration, but in practice, this is not systematic. Moreover, data on drug wastage in Intensive Care Units (ICU) are rare. GAME-OVER observational study aims to evaluate drug wastage in ICU in France and to suggest ways to improve health care practices.

Detailed description

Observational study with data collection during a 24-hour business day. Data collected refer to healthcare team's practices and patients. Collection starts when day shift starts (at 7:00 am) and ends when night shift leaves (at 7:00 am the following day).

Interventions

OTHERQuantification of IV drugs wastage

Drugs are prescribed depending on physician discretion. Specific collection bins are provided to ICU. Healthcare teams discard syringes labelled with name and dilution which have been used to prepare drugs into these bins. After 24 hours of collection, bins are analyzed by investigators.

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER
Sainte-Anne Military Teaching Hospital
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients hospitalized in intensive care units during the 24 hours of data collection.

Exclusion criteria

* Patient's opposition to participate in the study or patient family opposition if the patient is not able to be informed.

Design outcomes

Primary

MeasureTime frameDescription
Ratio of overall wastage in milliliter (mL) of prepared and discarded IV drugs to overall volume in milliliter (mL) of prepared IV drugs.24 hoursWastage is defined as any prepared and unused drug that remains in syringe or IV bag.

Secondary

MeasureTime frameDescription
Reason for discarding drug residues24 hoursA questionnaire will be fulfilled by healthcare teams with the following possible categories: 1/ prepared in advance and not used ; 2/ systematic change at fixed times ; 3/ prescription change ; 4/ change by anticipation of care ; 5/ drug no longer needed ; 6/ preparation error ; 7/ other reason.
Drug residues discarding process24 hoursA questionnaire will be used to determine which discarding process are applied by nurses in their usual pratices.
Use of enteral administration route24 hoursUse of enteral administration route versus per os and IV routes will be analyzed for paracetamol and proton pump inhibitor according to the accessibility of enteral route and the reason and the date of patient entry in ICU.
Cost of overall IV drug wastage24 hoursEstimated cost of drug residues will be evaluated for each drug, according to the reason for discarding, by the following formula : volume of discarded IV drugs x theoretical price

Countries

France, Mayotte, Monaco

Contacts

STUDY_DIRECTORErwan D'ARANDA, MD

Sainte-Anne Military Teaching Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026